Davis's Canadian Drug Guide for Nursesr
ISBN-10:
0803639775
ISBN-13:
9780803639775
Edition: First Edition
Description:
SAFETY FIRST!
Davis’s Canadian Drug Guide for Nurses®, Fourteenth Edition delivers all of the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs—along with the Canadian-specific information you want.
BONUS!
FREE DIGITAL ACCESS
One-year subscription to DrugGuide.com, Davis’s Drug Guide Online, powered by Unbound Medicine. You’ll have access to over 1,100 monographs from your desktop, laptop, or any mobile device with a web browser.
LIFE-SAVING GUIDANCE…AT A GLANCE
LEARNING, CARE PLANNING, AND PATIENT EDUCATION TOOLS
Online at DavisPlus
NEW! Student resources online at DavisPlus. (Redeem the Plus Code on the inside front cover of a new, printed text to access your DavisPlus resources.)
Student Resources
Additional Resources
Davis’s Canadian Drug Guide for Nurses®, Fourteenth Edition delivers all of the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs—along with the Canadian-specific information you want.
BONUS!
FREE DIGITAL ACCESS
One-year subscription to DrugGuide.com, Davis’s Drug Guide Online, powered by Unbound Medicine. You’ll have access to over 1,100 monographs from your desktop, laptop, or any mobile device with a web browser.
LIFE-SAVING GUIDANCE…AT A GLANCE
- Canadian-specific content
- Full monographs on drugs approved for use in Canada that are not FDA-approved for use in the US.
- Additional Canadian trade names for many US-approved generic drugs; identified by a maple leaf icon.
- A summary of the similarities and differences between pharmaceutical practices in the US and Canada.
- Canadian Advisory Board of clinicians, educators, and students.
- Red tab for high alert medications, plus in-depth high alert and patient safety coverage.
- Red, CAPITALIZED letters for life-threatening side effects.
- Drug-drug, drug-food, drug-natural product interactions.
- Pedi, Geri, OB, and Lactation cautions.
- IV Administration subheads.
- REMS (Risk Evaluation and Mitigation Strategies) icon.
- Pharmacogenomic content.
- Much more!
LEARNING, CARE PLANNING, AND PATIENT EDUCATION TOOLS
Online at DavisPlus
NEW! Student resources online at DavisPlus. (Redeem the Plus Code on the inside front cover of a new, printed text to access your DavisPlus resources.)
Student Resources
- More than 1,100 Nurse’s Med Deck-style, printable drug monographs for care planning and patient education
- Audio library for 1,200+ drug names
- Self-test tutorials
- Calculators for body mass index (BMI), metric conversions, IV drip rates, dosage/kg, and Fahrenheit/Celsius
- Interactive case studies
- NEW! Complementary and Alternative Medicine ‘Drag and Drop’ activity
Additional Resources
- Interactive flash cards
- Audio podcasts
- Video clips
- Animations
- Schematic brain illustrations
- Much more!
Best prices to buy, sell, or rent ISBN 9780803639775
Frequently Asked Questions about Davis's Canadian Drug Guide for Nursesr
You can buy the Davis's Canadian Drug Guide for Nursesr book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $10.22 on Amazon and is available from 8 sellers at the moment.
If you’re interested in selling back the Davis's Canadian Drug Guide for Nursesr book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Davis's Canadian Drug Guide for Nursesr book, the best buyback offer comes from and is $ for the book in good condition.
The Davis's Canadian Drug Guide for Nursesr book is in very low demand now as the rank for the book is 8,598,325 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.